<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01486225</url>
  </required_header>
  <id_info>
    <org_study_id>CVE401-10</org_study_id>
    <nct_id>NCT01486225</nct_id>
  </id_info>
  <brief_title>Tolerance Study of the Silicone Bands on Medical Compression Stockings</brief_title>
  <official_title>Exploratory Comparative Single-blind Study Evaluating Tolerability of the Silicone Bands on Medical Compression Stockings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Innothera</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Innothera</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify the nature of skin lesions that develop on contact&#xD;
      with the grip-top bands of medical compression stockings, which are composed mainly of&#xD;
      silicone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To identify the nature of lesions the investigator will analyse results of the biopsys,&#xD;
      microbiological analyses, dermatological tests.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>nature and outcome of skin lesion caused by the silicone from the grip-top band of medical stockings</measure>
    <time_frame>within 5 days from skin lesion started</time_frame>
    <description>Patient will be followed during 5 days from the time that lessions occurs</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Skin Lesions</condition>
  <arm_group>
    <arm_group_label>Innothera's brand Stokings</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Innothera's branded grip-top silicone band stokingc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other than Innothera's brand</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Innothera's brand Stockings</intervention_name>
    <description>15 patients having used Innothera branded Stocking</description>
    <arm_group_label>Innothera's brand Stokings</arm_group_label>
    <other_name>Medical compression stockings</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stockings other than Innothera's brand</intervention_name>
    <description>15 patients having used any other brand than Innothera's brand stockings</description>
    <arm_group_label>Other than Innothera's brand</arm_group_label>
    <other_name>Other Names:</other_name>
    <other_name>Medical compression stockings</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects who notified a health care professional (doctor or pharmacist) of an incident&#xD;
             with a grip-top bands compression stocking, regardless of brand and model.&#xD;
&#xD;
          -  Subjects presenting skin lesions caused by the contact with silicone-containing&#xD;
             grip-top bands of medical compression stockings (all brands combined).&#xD;
&#xD;
          -  Subjects for whom the incriminated stockings provide class 2 compression or higher.&#xD;
&#xD;
          -  Subjects covered by French national health insurance.&#xD;
&#xD;
          -  Subjects who give their written informed consent and who accept the constraints of the&#xD;
             study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known allergy to local anesthetics (lidocaine, etc.).&#xD;
&#xD;
          -  History of anaphylactic shock.&#xD;
&#xD;
          -  Ongoing antihistamine treatment or having taken during the week before inclusion.&#xD;
&#xD;
          -  Patient on ongoing systemic corticosteroids or having taken corticosteroids in the&#xD;
             month before inclusion.&#xD;
&#xD;
          -  Patient having used a topical corticosteroid in the area where the patch tests or&#xD;
             prick tests will be performed during the week before inclusion.&#xD;
&#xD;
          -  Phototherapy or sun exposure in the 30 days preceding the skin tests (on the back).&#xD;
&#xD;
          -  Patient having concomitantly used compression stockings and a topical corticosteroid&#xD;
             on the thighs in the 48 hours preceding lesion onset.&#xD;
&#xD;
          -  List of diseases which will prevent a subject from participating in the study:&#xD;
&#xD;
          -  acquired, infectious or drug-induced congenital immunosuppression (systemic&#xD;
             corticosteroid therapy, immunosuppressives, chemotherapy),&#xD;
&#xD;
          -  Congenital bullous disorder (congenital epidermolysis bullosa) or acquired bullous&#xD;
             disorder (pemphigus, pemphigoid, dermatitis herpetiformis, linear IgA dermatosis,&#xD;
             etc.).&#xD;
&#xD;
          -  Patients with an ongoing or previous history of mental or psychiatric disorder or&#xD;
             condition or any other factor interfering with the ability to give informed consent.&#xD;
&#xD;
          -  Any major systemic disease making the conduct of the study or the interpretation of&#xD;
             the results difficult.&#xD;
&#xD;
          -  Patients with ongoing or previous history of decompensated heart failure.&#xD;
&#xD;
          -  Chemotherapy or active cancer.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Patients participating in an ongoing clinical trial or in the exclusion period of a&#xD;
             previous trial.&#xD;
&#xD;
          -  Persons deprived of their liberty by judicial or administrative decision or persons&#xD;
             hospitalized without their consent.&#xD;
&#xD;
          -  Legally protected adults under guardianship.&#xD;
&#xD;
          -  If the patient accepts the biopsy proposed in the study:&#xD;
&#xD;
          -  Patient for whom a skin biopsy is contra-indicated or requiring antibiotic&#xD;
             prophylaxis,&#xD;
&#xD;
          -  Anticoagulant taken during the 24 hours before inclusion.&#xD;
&#xD;
          -  Subject with history of allergy to natural or synthetic latex, chlorhexidine, known&#xD;
             healing disorder and/or viral diseases transmissible through the blood documented by&#xD;
             the preliminary clinical exam.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annick BARBAUD, MD Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nancy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HÃ´pitaux de Brabois CHU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <study_first_submitted>August 10, 2011</study_first_submitted>
  <study_first_submitted_qc>December 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2011</study_first_posted>
  <last_update_submitted>August 7, 2014</last_update_submitted>
  <last_update_submitted_qc>August 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

